43Z.F Schrödinger, Inc.

Healthcare Health Information Services Frankfurt Exchange
32.67 EUR
Close of Nov 11, 2026
9.36 30.35
Market cap
EUR 2.14B
P/E
-
P/B
7.17x
ROE
-40.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 43Z.F undervalued?

Graham number

The Graham number of Schrödinger, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Schrödinger, Inc. fundamental analysis

No fundamental analysis for Schrödinger, Inc. yet.

Schrödinger, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug D…

Full company profile